Search Options Stock News and Analysis from Schaeffer's

SEARCH RESULTS FOR: "Tag: ALLO"

REFINE YOUR SEARCH

REFINE YOUR SEARCH:

ARTICLES/BLOGS

2021(1)

2020(1)

2019(2)

CATEGORIES

Analyst Update(2)

Buzz Stocks(2)

Intraday Option Activity(1)

Biotech Stock Hits Record Lows on FDA Hold

https://www.schaeffersresearch.com/content/news/2021/10/08/biotech-stock-hits-record-lows-on-fda-hold

10/8/2021 10:52 AM

Allogene Therapeutics Inc (NASDAQ:ALLO) is plummeting this morning, down 42% to trade at $14.13 at last check, one of the worst stock's on the Nasdaq today. This comes after the U.S Food and Drug Adm...

ALLO Hit With Bull Notes After Posting Positive Drug Data

https://www.schaeffersresearch.com/content/news/2020/05/14/allo-hit-with-bull-notes-after-posting-positive-drug-data

5/14/2020 9:34 AM

Allogene Therapeutics Inc (NASDAQ:ALLO) this morning released well-received data from its phase-one study of its non-Hodgkin lymphoma treatment, ALLO-501. The oncology firm expects to initiate the ne...

Analyst Names ALLO Stock a CAR-T Leader

https://www.schaeffersresearch.com/content/news/2019/11/04/analyst-names-allo-stock-a-car-t-leader

11/4/2019 9:16 AM

CAR-T therapy has been the big thing in oncology in recent years, and one name at the forefront of the immuno-oncology movement is Allogene Therapeutics Inc (NASDAQ:ALLO). In fact, Canaccord Genuity ...

Oppenheimer Likes This Cancer Stock Before Earnings

https://www.schaeffersresearch.com/content/news/2019/05/03/oppenheimer-likes-this-cancer-stock-before-earnings

5/3/2019 2:08 PM

Ahead of earnings next Tuesday, May 7, Oppenheimer initiated coverage of Allogene Therapeutics Inc (NASDAQ:ALLO) with an "outperform" rating. In addition, the brokerage firm set a lofty price targe...

PEOPLE ALSO SEARCH FOR

ALLO